Magnus Financial Group LLC Cytokinetics Inc Transaction History

Magnus Financial Group LLC

  • $971 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$20.58 - $28.96 $248,338 - $349,460
-12,067 Closed
0 $0
Q1 2020

May 11, 2020
BUY
$8.75 - $16.3 $2,161 - $4,026
247 Added 2.09%
12,067 $142,000
Q4 2018

Feb 13, 2019
BUY
$5.91 - $9.29 $69,856 - $109,807
11,820 New
11,820 $75,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.76B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email